Skip to main content Accessibility help
×
Home
  • Print publication year: 2005
  • Online publication date: August 2010

37 - Approach to the patient presenting with parkinsonism

from Part VII - Parkinson's and related movement disorders

Summary

General symptomatology of patients with parkinsonism

In the nearly 200 years since James Parkinson's original essay on ‘shaking palsy’ (Parkinson, 1817), clinicians have learned that he described a syndrome rather than a specific disease and that Parkinson's has many imitators. As a syndrome, parkinsonism is characterized by tremor, bradykinesia, rigidity and postural reflex compromise. Parkinson's disease is one of many parkinsonian syndromes and is defined by the same clinical signs in association with a distinct type and pattern of cellular degeneration. Parkinsonism can occur as an isolated clinical syndrome, classified as primary when it is due to hereditary or idiopathic causes or secondary when it has another identifiable underlying etiology. When parkinsonism occurs in association with other neurological signs, it is classified as one of the well-defined parkinsonism-plus syndromes or as parkinsonism associated with defined hereditodegenerative disorders (Table 37.1). Parkinson's disease is the archetype of primary parkinsonism. A thorough history and comprehensive examination can usually differentiate Parkinson's disease from other parkinsonian syndromes. Nevertheless, clinicopathological studies have shown that 20% of patients thought clinically to have Parkinson's disease turn out to have pathological cellular changes suggestive of other diagnoses, and 5–10% of parkinsonian subjects with an atypical clinical picture for Parkinson's disease have the typical cellular changes of Parkinson's disease at autopsy (Hughes et al., 2001).

Unilateral tremor is the most common initial symptom resulting in medical consultation for Parkinson's disease.

REFERENCES
Agid, Y., Cervera, P., Hirsch, E.et al. (1989). Biochemistry of Parkinson's disease 28 years later: a critical review. Mov. Disord., 4, S126–44
Bennett, D. A., Beckett, L. A., Murray, A. M.et al. (1996). Prevalence of parkinsonian signs and associated mortality in a community population of older people. N. Engl. J. Med., 334, 71–6
Bergeron, C., , Davis, A., & Lang, A. E. (1998). Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol., 8, 355–65
Bower, J. H., Maraganore, D. M., McDonnell, S. K. & Rocca, W. A. (1997). Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology, 49, 1284–8
Bower, J. H., Maraganore, D. M., McDonnell, S. K. & Rocca, W. A. (1999). Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990. Neurology, 52, 1214–20
Brooks, D. J. (1997). Neuroimaging of movement disorders. In Movement Disorders, Neurologic Principles and Practice, ed. R. L. Watts & W. C. Koller, pp. 31–48. New York, NY: McGraw-Hill
Colosimo, C., Albanese, A., Hughes, A. J., Bruin, V. M. & Lees, A. J. (1995). Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch. Neurol., 52, 294–8
Dickson, D. W. (1999). Tau and synuclein and their role in neuropathology. Brain Pathol., 9, 657–61
Duda, J. E., Lee, V. M. & Trojanowski, J. Q. (2000). Neuropathology of synuclein aggregates. J. Neurosci. Res., 61, 121–7
Duguid, J. R., Paz, R. & DeGroot, J. (1986). Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann. Neurol., 20, 744–7
Feany, M. B. & Dickson, D. W. (1996). Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann. Neurol., 40, 139–48
Galvin, J. E., Lee, V. M. & Trojanowski, J. Q. (2001), Synucleinopathies: clinical and pathological implications. Arch. Neurol., 58, 186–90
Gelb, D. J., Oliver, E. & Gilman, S. Research diagnostic criteria for Parkinson's disease. In Parkinson's Disease: Anatomy, Pathology, and Therapy, ed. M. Streifler, A. Korczyn, E. Melamed & M. Youdim. New York: Raven Press
Gilman, S., Low, P. A. & Quinn, N. P. (1999). Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci., 163, 94–8
Golbe, L. I. (1994). The epidemiology of PSP. J. Neural. Transm. Suppl 42, 263–73
Golbe, L. I. (1996). The epidemiology of progressive supranuclear palsy. Adv. Neurol., 69, 25–31
Golbe, L. I. (1997). Progressive supranuclear palsy. In Movement Disorders: Neurologic Principles and Practice, ed. R. L. Watts & W. C. Koller, pp. 279–95. New York, NY: McGraw-Hill
Gorell, J. M., Ordidge, R. J., Brown, G. G., Deniau, J. C., Buderer, N. M. & Helpern, J. A. (1995). Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology, 45, 1138–43
Hauw, J. J., Daniel, S. E., Dickson, D., et al. (1994). Preliminary NINDS neuropathologic criteria for Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy). Neurology, 44, 2015–19
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatr., 55, 181–4
Hughes, A. J., Ben-Shlomo, Y., , Daniel, S. E. & Lees, A. J. (2001). What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study 1992. Neurology, 57, S34–8
Hutton, M., Lendon, C. L., Rizzu, P.et al. (1998). Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393, 702–5
Jankovic, J. (1989). Parkinsonism-plus syndromes. Mov. Disord., 4 Suppl 1, S95–119
Jellinger, K. A. (1998). Neuropathology of movement disorders. Neurosurg. Clin. N. Am., 9, 237–62
Jellinger, K. A. (1996). The neuropathologic diagnosis of secondary parkinsonian syndromes. In Parkinson's Disease, ed. L. Battistin, G. Scarlato, T. Caraceni & S. Ruggieri, pp. 293–303. Philadelphia, PA: Lippincott-Raven
Lee, V. M., Goedert, M., & Trojanowski, J. Q. (2001). Neurodegenerative tauopathies. Annu. Rev. Neurosci., 24, 1121–59
Litvan, I., Agid, Y., Jankovic, J.et al. (1996). Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome). Neurology, 46, 922–30
Litvan, I., Goetz, C. G. & Jankovic, J. (1997). What is the accuracy of the clinical diagnosis of multiple system atrophy. Arch. Neurol., 54, 937–44
Litvan, I., MacIntyre, A., Goetz, C. G.et al. (1998). Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch. Neurol., 55, 969–78
Mayeux, R., Stern, Y., Rosen, J. & Leventhal, J. (1981). Depression, intellectual impairment, and Parkinson disease. Neurology, 31, 645–50
Mayeux, R., Chen, J., Mirabello, E.et al. (1990). An estimate of the incidence of dementia in idiopathic Parkinson's disease. Neurology, 40, 1513–17
Magalhaes, M., Wenning, G. K., Daniel, S. E. & Quinn, N. P. (1995). Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease – a retrospective comparison. Acta Neurol. Scand., 91, 98–102
Mastaglia, F. L., Grainger, K., Kee, F., Sadka, M. & Lefroy, R. (1973). Progressive supranuclear palsy (the Steele–Richardson–Olszewski syndrome): clinical and electrophysiological observations in eleven cases. Proc. Aust. Assoc. Neurol., 10, 35–44
Moleman, P., Janzen, G., Bargen, B. A., Kappers, E. J., Pepplinkhuizen, L. & Schmitz, P. I. (1986). Relationship between age and incidence of parkinsonism in psychiatric patients treated with haloperidol. Am. J. Psychiatr., 143, 232–4
Morris, H. R., Lees, A. J. & Wood, N. W. (1999). Neurofibrillary tangle parkinsonian disorders – tau pathology and tau genetics. Mov. Disord., 14, 731–6
Parkinson, J. (1817). An Essay on the Shaking Palsy. London, Whittingham and Rowland for Sherwood, Neely and Jones
Pastakia, B., Polinsky, R., Di Chiro, G., Simmons, J. T., Brown, R. & Wener, L. (1986). Multiple system atrophy (Shy–Drager syndrome): MR imaging. Radiology, 159, 499–502
Paulson, H. L. & Stern, M. B. (1997). Clinical manifestations of Parkinson's disease. In Movement Disorders: Neurologic Principles and Practice, ed. R. L. Watts & W. C. Koller, pp. 183–99. New York, NY: McGraw-Hill
Pfeiffer, R. F. (1997). Wilson's disease. In Movement Disorders, Neurologic Principles and Practice, ed. R. L. Watts & W. C. Koller, pp. 623–37. New York, NY: McGraw-Hill
Polymeropoulos, M. H., Lavedan, C., Leroy, E.et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [see comments]. Science, 276, 2045–7
Quinn, N. (1989). Multiple system atrophy – the nature of the beast. J. Neurol. Neurosurg. Psychiatr., Suppl, 78–89
Rajput, A. H., Offord, K. P., Beard, C. M. & Kurland, L. T. (1989). Epidemiology of parkinsonism: incidence, classification, and mortality. Ann. Neurol., 16, 278–82
Rajput, A. H., Rozdilsky, B., & Rajput, A., (1991). Accuracy of clinical diagnosis in parkinsonism – a prospective study. Can. J. Neurol. Sci., 18, 275–8
Rutledge, J. N., Hilal, S. K., Silver, A. J., Defendini, R. & Fahn, S. (1987). Study of movement disorders and brain iron by MR. Am. J. Roentgenol., 149, 365–79
Saito, T. (1981). An assessment of efficiency in potential screening for Wilson's disease. J. Epidemiol. Commun. Hlth., 35, 274–80
Savoiardo, M., Strada, L., Girotti, F.et al. (1990). Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology, 174, 693–6
Savoiardo, M., Halliday, W. C., Nardocci, N.et al. (1993). Hallervorden–Spatz disease: MR and pathologic findings. Am. J. Neuroradiol., 14, 155–62
Savoiardo, M., Girotti, F., Strada, L. & Ciceri, E. (1994). Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J. Neural. Transm. Supp., 42, 93–110
Savoiardo, M., Grisoli, M. & Girotti, F. (2000). Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias. Adv. Neurol. 82, 197–208
Schrag, A., Ben-Shlomo, Y. & Quinn, N. P. (1999). Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet, 354, 1771–5
Shulman, L. M. & Weiner, W. J. (1997). Multiple-system atrophy. In Movement Disorders, Neurologic Principles and Practice, ed. R. L. Watts & W. C. Koller, pp. 297–306. New York, NY: McGraw-Hill
Snow, B. J., Vingerhoets, F. J., Langston, J. W., Tetrud, J. W., Sossi, V. & Calne, D. B. (2000). Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism. J. Neurol. Neurosurg. Psychiatr., 68, 313–16
Tanner, C. M. & Goldman, S. M. (1996). Epidemiology of Parkinson's disease. Neurol. Clin., 14, 317–35
Trojanowski, J. Q. & Lee, V. M. (2000). ‘Fatal attractions’ of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann. NY Acad. Sci., 924, 62–7
Vanacore, N., Bonifati, V., Fabbrini, G.et al. (2001a). Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol. Sci., 22, 97–9
Vanacore, N., Bonifati, V., Colosimo, C.et al. (2001b). Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol. Sci., 22, 101–3
Wassenaer-van Hall, H. N., Heuvel, A. G., Algra, A., Hoogenraad, T. U. & Mali, W. P. (1996). Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology, 198, 531–6
Vidailhet, M., Rivaud, S., Gouider-Khouja, N.et al. (1994). Eye movements in parkinsonian syndromes. Ann. Neurol., 35, 420–6
Wakabayashi, K., Oyanagi, K., Makifuchi, T.et al. (1994). Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol. (Berl.), 87, 545–53
Weiner, W. J. & Lang, A. E. (1989). Movement Disorders: A Comprehensive Survey. New York, NY: Futura Publishing Company
Wenning, G. K., Ben-Shlomo, Y., Hughes, A., , Daniel, S. E., Lees, A. & Quinn, N. P. (2000). What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?J. Neurol. Neurosurg. Psychiatr., 68, 434–40
Yamanouchi, H. & Nagura, H. (1997). Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. Stroke, 28, 965–9